Category: Sotrovimab

COVID-19 Therapeutics for Nonhospitalized Patients

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Therapeutics for Nonhospitalized Patients

Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint summarizes currently available therapeutics for nonhospitalized patients in the setting of the Omicron variant including principles for equitable allocation. Patients with mild or moderate COVID-19 […]

“Inescapable” COVID-19 Antibody Discovery – Neutralizes All Known SARS-CoV-2 Strains

Posted on | Posted on John Murphy | Leave a Comment on “Inescapable” COVID-19 Antibody Discovery – Neutralizes All Known SARS-CoV-2 Strains

Authors: By LAWRENCE BERKELEY NATIONAL LABORATORY AUGUST 26, 2021 An antibody therapy that appears to neutralize all known SARS-CoV-2 strains, and other coronaviruses, was developed with a little help from structural biologist Jay Nix. Lifesaving COVID-19 vaccines are allowing us to feel optimistic again, after more than a year of anxiety and tragedy. But vaccines are only one side of the […]